Compound Summary
brimonidine
Compound Information
brimonidine
Compound Name: | brimonidine |
Compound CID: | 2435 |
Synonyms: | brimonidine 59803-98-4 Bromoxidine UK 14,304 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine More... |
Iupac Name: | 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine |
InChI: | InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17) |
InChIKey: | XYLJNLCSTIOKRM-UHFFFAOYSA-N |
Canonical Smiles: | C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br |
Isomeric Smiles: | C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br |
Molecular Weight: | 292.13 |
Molecular Formula: | C11H10BrN5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
brimonidine
Molecular Weight: | 292.13 |
Molecular Formula: | C11H10BrN5 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 17 |
Complexity: | 308 |
Synonyms
brimonidine
| brimonidine | brimonidine |
|---|---|
brimonidine |
59803-98-4 |
Bromoxidine |
UK 14,304 |
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine |
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine |
5-bromo-6-(imidazolin-2-ylamino)quinoxaline |
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline |
AGN 190342 |
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- |
UK-14304 |
UNII-E6GNX3HHTE |
UK 14304 |
AGN-190342 |
MLS000069370 |
E6GNX3HHTE |
CHEMBL844 |
SMR000058355 |
CHEBI:3175 |
MFCD00153878 |
NCGC00016069-09 |
UK 14304;AGN190342 |
DSSTox_CID_25221 |
DSSTox_RID_80758 |
DSSTox_GSID_45221 |
UK 14304 (tartrate);AGN190342 (tartrate) |
5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine |
Brimonidine INN:BAN |
3Hbrimonidine |
C11H10BrN5 |
CAS-59803-98-4 |
N-(5-bromoquinoxalin-6-yl)imidazolidin-2-imine |
SR-01000000023 |
brimonidina |
brimonidinum |
BRN 0751629 |
Brimonidine-d4 |
LK 14304-18 |
Brimonidine (INN) |
AGN190342 |
UK14304 |
Tocris-0425 |
3H-UK14304 |
Opera_ID_612 |
Lopac-U-104 |
cid_2435 |
Lopac0_001216 |
SCHEMBL24670 |
GTPL520 |
MLS001076349 |
ARONIS24406 |
BIDD:GT0649 |
GTPL5386 |
DTXSID3045221 |
BDBM34572 |
AGN-190342 FREE BASE |
HMS3259P09 |
HMS3263D14 |
HMS3266O03 |
HMS3411K05 |
HMS3675K05 |
HMS3887K07 |
AMY22318 |
BCP12632 |
EX-A5415 |
HY-B0659 |
Tox21_110299 |
Tox21_501216 |
UK-1430418 FREE BASE |
AC-162 |
NSC318825 |
PDSP1_000640 |
PDSP2_000635 |
s9508 |
SBB080815 |
ZINC21303210 |
AKOS005267239 |
Tox21_110299_1 |
CCG-205290 |
DB00484 |
GS-3236 |
LP01216 |
MCULE-4542695850 |
NC00638 |
NSC 318825 |
NSC-318825 |
SDCCGSBI-0051183.P002 |
MRF-0000657 |
NCGC00016069-01 |
NCGC00016069-02 |
NCGC00016069-03 |
NCGC00016069-04 |
NCGC00016069-05 |
NCGC00016069-06 |
NCGC00016069-07 |
NCGC00016069-08 |
NCGC00016069-10 |
NCGC00016069-11 |
NCGC00016069-12 |
NCGC00016069-13 |
NCGC00016069-24 |
NCGC00023468-02 |
NCGC00023468-04 |
NCGC00023468-05 |
NCGC00023468-06 |
NCGC00023468-07 |
NCGC00261901-01 |
UK14,304 |
Brimonidine 100 microg/mL in Acetonitrile |
B4132 |
EU-0101216 |
FT-0630717 |
FT-0650586 |
EN300-50880 |
UK 14304-18 |
C07886 |
C75796 |
D07540 |
5-bromo-6-(2-imidazolidinylidenamino)quinoxaline |
5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline |
5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline |
6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)- |
(5-bromoquinoxalin-6-yl)-2-imidazolin-2-ylamine |
803B984 |
A832477 |
L000615 |
Q577377 |
SR-01000000023-2 |
SR-01000000023-4 |
BRD-K68264559-001-10-0 |
Z802671510 |
(5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine |
5-bromanyl-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine |
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- (9CI) |
Experimental Data
brimonidine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 5.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
brimonidine
Statistics Data
brimonidine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | 1 | 1 |
Statistics Data Visualization
brimonidine
